Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation
Metzgeroth, G, Erben, P, Martin, H, Mousset, S, Teichmann, M, Walz, C, Klippstein, T, Hochhaus, A, Cross, N C P, Hofmann, W-K, Reiter, AVolume:
26
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2011.181
Date:
January, 2012
File:
PDF, 152 KB
english, 2012